title: Prevention: HOPE-3 trial - targeting BP and LDL-C in at-risk patients.
authors.affiliation: Department of Preventive Medicine and Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, 680 North Lake Shore Drive, Chicago, Illinois 60611, USA.
authors.forename: John T
authors.initials: JT
authors.lastname: Wilkins
authors.affiliation: Department of Preventive Medicine and Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, 680 North Lake Shore Drive, Chicago, Illinois 60611, USA.
authors.forename: Donald M
authors.initials: DM
authors.lastname: Lloyd-Jones
mesh_terms: D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood; D050171:Dyslipidemias / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors